Regeneron Ventures

Activity in this selectionan-ventures-06122ff2

By stage

Series A2

Series B1

Biotech3

United States3

3 in this selection

Aug 11

Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease

$75MSeries A

Role not disclosed

Jun 8

Develops next-generation RNAi therapeutics and engineering platform for multiple disease areas

$99.5MSeries B

Role not disclosed

Jan 20

Develops small molecule drugs for historically challenging drug targets

$55MSeries A

Role not disclosed